Depression and anxiety in childhood-onset systemic lupus erythematosus: prevalence, associated factors, and impact on quality of life and family

被引:0
|
作者
Duangmala, Pitsamai [1 ]
Sontichai, Watchareewan [2 ]
机构
[1] Chiang Mai Univ, Fac Med, Dept Pediat, Chiang Mai, Thailand
[2] Chiang Mai Univ, Fac Med, Dept Pediat, Div Rheumatol, Chiang Mai 50200, Thailand
关键词
Anxiety; Depression; Family; Quality of life; Systemic lupus erythematosus; PSYCHOMETRIC PROPERTIES; COMORBID ANXIETY; CHRONIC DISEASE; RISK-FACTORS; SYMPTOMS; FATIGUE; SCREEN; DAMAGE; INDEX; SLE;
D O I
10.1186/s12969-025-01067-6
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background Depression and anxiety are common psychiatric manifestations in childhood-onset systemic lupus erythematosus (cSLE). This study aimed to determine the prevalence of clinically significant depression and anxiety, identify associated factors, and assess their impact on health-related quality of life (HRQOL) and family in patients with cSLE. Methods We conducted a cross-sectional study of cSLE patients, aged 8-18 years. Patients completed the Children's Depression Inventory (CDI), Screening for Child Anxiety Related Disorders (SCARED), Pediatric Quality of Life Inventory Generic Core Scale (PedsQL-GC), and Visual Analog Scale of pain intensity. Their parents completed the Pediatric Quality of Life Family Impact module (PedsQL family impact). Results Of 91 patients, the median disease duration was 3.4 years (IQR 3.5), and the median SLE disease activity index 2000 score was 2 (IQR 6). The prevalence of clinically significant depression (CDI > 15) and clinically significant anxiety (SCARED >= 25) were 31.9% and 49.5%, respectively. Coexisting clinically significant depression and anxiety were found in 26 patients (28.6%). In multivariable analyses, older age at diagnosis was associated with clinically significant depression (OR 1.56, 95% CI 1.12-2.16, p = 0.008), while organ damage (OR 4.27, 95% CI: 1.19-15.31, p = 0.026) and pain score (OR 1.61, 95% CI: 1.11-2.32, p = 0.012) were associated with clinically significant anxiety. Patients with clinically significant depression or anxiety had significantly lower PedsQL-GC and PedsQL family impact scores compared to those without these symptoms. Conclusions These results suggest that depression and anxiety are prevalent in cSLE and have negative impacts on HRQOL and family. Physicians should be aware of the presence of these psychological symptoms, particularly in patients with risk factors. Providing psychological counseling and prompt referral to psychiatrists could enhance HRQOL and family functioning.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Obesity and Cytokines in Childhood-Onset Systemic Lupus Erythematosus
    Sinicato, Nailu Angelica
    Postal, Mariana
    Peres, Fernando Augusto
    Pelicari, Karina de Oliveira
    Marini, Roberto
    dos Santos, Allan de Oliveira
    Ramos, Celso Dario
    Appenzeller, Simone
    JOURNAL OF IMMUNOLOGY RESEARCH, 2014, 2014
  • [42] Abdominal manifestations in childhood-onset systemic lupus erythematosus
    Richer, O.
    Ulinski, T.
    Lemelle, I.
    Ranchin, B.
    Loirat, C.
    Piette, J. C.
    Pillet, P.
    Quartier, P.
    Salomon, R.
    Bader-Meunier, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (02) : 174 - 178
  • [43] Rituximab therapy for childhood-onset systemic lupus erythematosus
    Willems, M.
    Haddad, F.
    Niaudet, F.
    Kone-Paut, I.
    Bensman, A.
    Cochat, P.
    Deschenes, G.
    Fakhouri, F.
    Leblanc, T.
    Llanas, B.
    Loirat, C.
    Pillet, F.
    Ranchin, B.
    Salomon, R.
    Ulinski, T.
    Bader-Meunier, Brigitte
    JOURNAL OF PEDIATRICS, 2006, 148 (05): : 623 - 627
  • [44] Social phobia in childhood-onset systemic lupus erythematosus
    Catia Nascimento
    Renata Barbosa
    Luciana Oliveira
    Karina Peliçari
    Nailu Sinicato
    Roberto Marini
    Paula Fernandes
    Simone Appenzeller
    Pediatric Rheumatology, 12 (Suppl 1)
  • [45] Cognitive Functions In Childhood-Onset Systemic Lupus Erythematosus
    Bellini, Bruna
    de Souza, Cleonice
    Postal, Mariana
    Sinicato, Nailu A.
    Fernandes, Paula T.
    Marini, Roberto
    Appenzeller, Simone
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S531 - S532
  • [46] Academic Outcomes in Childhood-Onset Systemic Lupus Erythematosus
    Zelko, Frank
    Beebe, Dean
    Baker, Aimee
    Nelson, Shannen M.
    Ali, Aisha
    Cedeno, Adlin
    Dina, Blair
    Klein-Gitelman, Marisa S.
    Ying, Jun
    Brunner, Hermine I.
    ARTHRITIS CARE & RESEARCH, 2012, 64 (08) : 1167 - 1174
  • [47] Neuropsychiatric manifestations in childhood-onset systemic lupus erythematosus
    Appenzeller, Simone
    Pereira, Danilo Rodrigues
    Julio, Paulo Rogerio
    Reis, Fabiano
    Rittner, Leticia
    Marini, Roberto
    LANCET CHILD & ADOLESCENT HEALTH, 2022, 6 (08): : 571 - 581
  • [48] An Update on the Management of Childhood-Onset Systemic Lupus Erythematosus
    Trindade, Vitor Cavalcanti
    Carneiro-Sampaio, Magda
    Bonfa, Eloisa
    Silva, Clovis Artur
    PEDIATRIC DRUGS, 2021, 23 (04) : 331 - 347
  • [49] Pharmacological Management of Childhood-Onset Systemic Lupus Erythematosus
    Thorbinson, Colin
    Oni, Louise
    Smith, Eve
    Midgley, Angela
    Beresford, Michael W.
    PEDIATRIC DRUGS, 2016, 18 (03) : 181 - 195
  • [50] Cost of treatment of childhood-onset systemic lupus erythematosus
    Brunner, HI
    Sherrard, TM
    Klein-Gitelman, MS
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2006, 55 (02): : 184 - 188